Oxford, UK – 25th October 2017 – OxSonics Limited, a world leader in the development of ultrasound-based drug delivery systems for the treatment of cancer patients, today announced that Glyn Edwards is to join the board as Non-Executive Director. Glyn Edwards has held the position of CEO of Summit plc since April 2012 where he […]
Oxford, UK – 26 September 2017 – OxSonics Limited, today announced it has expanded its operations in Oxford and moved into newly developed state of the art laboratories and offices. The newly customized facilities occupy the entire East wing of the second floor of the “Magdalen Centre North” building and spans over 4,800 square feet. […]
Oxford, UK – 1 September 2017 – OBN Ltd, the membership organisation supporting the UK’s innovative life sciences companies has announced the finalists of its 8th Annual Awards covering Biotech, Medtech, Synthetic Biology and Digital Health. The OBN Awards remain proudly independent, celebrating innovation and achievement across the UK life sciences industry and recognising achievements […]
Oxford, UK – 9th January 2017 – OxSonics® Limited today announced that over £9.4 million of Series B equity financing had been successfully raised. The funding was provided by a combination of new and existing investors, including Longwall Venture Partners, Oxford Technology Innovation EIS Fund, the University of Oxford, Winton Ventures, Perivoli Innovations as well […]
Oxford, UK – 15 April 2016 – a University of Oxford spin-out company developing a new generation of ultrasound-based medical devices, today announced that members of the co-founding team and R&D team of OxSonics have won the 2016 “Jorge Heller Journal of Controlled Release Outstanding Paper Award”, which specifically recognizes major advances in the delivery […]
Oxford, UK – 5 October 2015 – OxSonics Limited (“OxSonics”), University of Oxford spin-out company developing a new generation of ultrasound-based medical devices, today announced it had won the award for the “Best Emerging UK Medtech Company” at the OBN annual award ceremony. The awards celebrate the key achievements within the UK’s bioscience and medical […]
Oxford, UK – 23 June 2015 – OxSonics Limited (“OxSonics”) has entered into a long-term contract development and manufacturing partnership with Juniper Pharma Services Ltd. (“Juniper”). Juniper will support OxSonics in the formulation development, scale-up and GMP manufacturing of OxSonics’ proprietary injectable “sono-sensitive particles”. OxSonics was established in July 2013 to develop and commercialise a […]
London, UK – 2 April 2015 – OxSonics was featured in the latest issue of MoneyWeek Magazine, the UK’s best-selling financial magazine. To view the article please visit: http://moneyweek.com/penny-sleuth-oxford-university-spin-out-oxsonics/ PDF version
London, UK – 15 January 2015 – The Medicines and Healthcare products Regulatory Agency (“MHRA”) has helped OxSonics take a big step towards developing a revolutionary generation of ultrasound devices which aim to enhance delivery of anti-cancer drugs deep into solid tumours. OxSonics Limited (“OxSonics”) was established in July 2013 to develop and commercialise a […]
Oxford, UK – 21 August 2014 – OxSonics Limited (“OxSonics”), a University of Oxford spin-out company developing a new generation of ultrasound-based medical devices, today announced it has been nominated and shortlisted as a finalist in the national OBN awards in the category of “Best New Medtech Development Programme”. OxSonics was established in July 2013 […]
© OxSonics Ltd
The Magdalen Centre
